As we close the book on 2022 it is time to look at how far the AIBN has come during the year, and how we are setting ourselves up for an even bigger 2023.
University of Queensland researchers have pioneered a new chemical process to manufacture the molecules that are the building blocks for lifesaving medicines, vaccines and energy storage materials.
Our researchers have developed an innovative and potentially life-saving diagnostic device – the Immuno-storm chip – that identifies which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.
AIBN researchers have developed a diagnostic device, called an Immuno-storm chip, that could identify which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.
Nanotechnology developed to detect cancer can also identify signals released by cancer cells, possibly resulting in earlier diagnosis and better treatment.
Three Early Career Researchers at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) have been awarded nearly $2 million in Investigator Grants from the National Health and Medical Research Council (NHMRC).
